ImmunityBio Inc.
IBRX | NASDAQ
$8.89
+$0.44 (+5.21%)
Sep 22, 2026, 11:33 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 75.67M | 205.19M | 88.33M | 60.24M | 137.66M | 60.66M | 143.43M | 111.97M | 130.1M | 133.04M | 265.45M | 177.96M | 43.51M | 88.48M | 104.64M | 104.16M | 61.9M | 36.39M | 181.1M | 64.52M | 83.96M | 44.68M |
Short-Term Investments | 281.7M | 175.69M | 154.48M | 197.57M | 16M | 931K | 6.38M | 18.4M | 87.88M | 37.46M | 1.01M | 11.83M | 2.45M | 2.79M | 2.54M | 6.9M | 21.04M | 155.95M | 136.02M | 15.85M | 19.97M | 38.59M |
Long-Term Investments | n/a | 10M | 10.48M | 8.02M | 7.95M | 7.19M | 700K | n/a | n/a | n/a | 891K | 817K | 841K | 820K | 840K | 811K | 914K | 865K | 6.78M | 8.27M | 822K | 8.18M |
Other Long-Term Assets | 189.52M | 24.72M | 15.05M | 167M | 2.98M | 4.91M | 11.26M | 10.71M | 9.66M | 9.67M | 9.7M | 10.24M | 10.53M | 11.24M | 11.49M | 12.51M | 6.02M | 12.76M | 7.2M | 6.29M | 12.94M | 916K |
Receivables | n/a | 43.27M | 42.62M | 33.72M | 22.33M | 17.45M | 2.65M | 4.9M | 2.06M | 2.14M | 3.17M | 2.33M | 3.28M | 1.46M | 1.89M | 6.49M | 1.45M | 3.89M | 1.33M | 1.3M | 2.05M | 2.06M |
Inventory | n/a | 547K | 910K | 6.7M | 6.64M | 8.44M | 8.27M | 1.96M | 1.81M | n/a | n/a | n/a | n/a | n/a | n/a | 19.85M | n/a | 12.13M | n/a | n/a | n/a | n/a |
Other Current Assets | 81.61M | 3.91M | 2.14M | 2.51M | 1.64M | 2.35M | 1.3M | 1.66M | 955K | 3.31M | 5.21M | 6.72M | 4.55M | 4.79M | 4.32M | 5.7M | 8M | 3.98M | 5.56M | 12.78M | 910K | 14.24M |
Total Current Assets | 438.98M | 452.95M | 314.88M | 329.5M | 208.13M | 109.16M | 184.59M | 163.15M | 242.83M | 195.72M | 294.08M | 215.08M | 66.83M | 113.49M | 140.58M | 143.09M | 114.99M | 212.34M | 334.35M | 94.45M | 113.73M | 99.57M |
Property-Plant & Equipment | n/a | 146.08M | 147.55M | n/a | 168.03M | 167.05M | 170.46M | 174.23M | 175.77M | 178.71M | 182.68M | 187.81M | 194.04M | 198.36M | 189.45M | 176.87M | 167.55M | 141.11M | 119.17M | 103.98M | 117.25M | 99.32M |
Goodwill & Intangibles | n/a | 12.89M | 13.95M | 14.48M | 14.98M | 15.44M | 15.93M | 16.48M | 16.06M | 16.57M | 17.09M | 18.47M | 18.99M | 19.5M | 20M | 20.47M | 21.74M | 22.35M | 1.42M | 1.43M | 1.56M | 1.44M |
Total Long-Term Assets | 189.52M | 193.68M | 187.02M | 189.49M | 193.94M | 194.6M | 198.35M | 201.42M | 201.5M | 204.96M | 210.37M | 217.34M | 224.4M | 229.91M | 221.78M | 209.85M | 202.73M | 177.25M | 134.56M | 119.97M | 132.57M | 109.86M |
Total Assets | 628.5M | 646.64M | 501.9M | 518.99M | 402.08M | 303.76M | 382.93M | 364.57M | 444.33M | 400.68M | 504.45M | 432.42M | 291.23M | 343.4M | 362.36M | 352.94M | 317.72M | 389.59M | 468.91M | 214.42M | 246.3M | 209.43M |
Account Payables | n/a | 11.19M | 6.98M | 5.77M | 7.42M | 13.5M | 6.73M | 9.95M | 20.32M | 13.87M | 9.2M | 19.82M | 25.49M | 33.57M | 21.02M | 20.24M | 18.05M | 9.83M | 11.42M | 15.12M | 19.15M | 20.1M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K | -1.4M | 100K | n/a | 145K | 217K | 263K |
Short-Term Debt | 7.51M | 884K | 9.29M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 518.51M | 471.48M | 431.9M | n/a | 300.08M | 299.61M | 299.24M | 7.21M | n/a | 5.73M |
Other Current Liabilities | 69.22M | 3.33M | 25.42M | 43.6M | 17.02M | 12.18M | 15.98M | 18.1M | 13.55M | 9.29M | 18.31M | 15.97M | 25.1M | 20.96M | 19.74M | 15.7M | 13.03M | 10.23M | 49.72M | 38.94M | 8.67M | 49.43M |
Total Current Liabilities | 76.73M | 67.95M | 61.75M | 57.13M | 50.64M | 49.21M | 54.94M | 60.96M | 62.11M | 53.76M | 58.28M | 90.32M | 613.48M | 564.95M | 500.86M | 70.84M | 376.05M | 381.01M | 369M | 65.41M | 74.43M | 79.86M |
Long-Term Debt | 31.2M | 1.08B | 835.16M | 500.8M | 492.08M | 485.72M | 461.88M | 699.12M | 692.92M | 687.09M | 681.54M | 673.59M | 250.1M | 245.64M | 241.27M | 710.62M | 363.19M | 345.68M | 306.35M | 303.24M | 300.25M | 297.29M |
Other Long-Term Liabilities | 1.57B | 331.77M | 70.89M | 450.33M | 393.33M | 326.22M | 319.42M | 311.89M | 350.25M | 312.62M | 310.63M | 39.84M | 28.27M | 18.24M | 22.09M | -48.99M | -50.36M | -35.96M | 249K | 905K | 920K | 891K |
Total Long-Term Liabilities | 1.6B | 1.45B | 939.72M | 985.26M | 921.25M | 845.04M | 816.12M | 1.05B | 1.08B | 1.04B | 1.03B | 752.74M | 322.93M | 310.17M | 311.32M | 711.18M | 363.64M | 346.13M | 343.83M | 338.96M | 330.46M | 314.9M |
Total Liabilities | 1.67B | 1.52B | 1B | 1.04B | 971.9M | 894.24M | 871.06M | 1.11B | 1.14B | 1.09B | 1.09B | 843.06M | 936.41M | 875.12M | 812.18M | 782.02M | 739.69M | 727.14M | 712.82M | 404.37M | 404.89M | 394.76M |
Total Debt | 38.71M | 1.12B | 878.12M | 542.25M | 535.32M | 526.27M | 504.17M | 742.91M | 735.59M | 731.37M | 726.72M | 717.27M | 819.16M | 766.25M | 723.77M | 761.54M | 715.33M | 685.05M | 645.66M | 345.09M | 331.8M | 319.57M |
Book Value | -1.05B | -869.13M | -499.57M | -523.41M | -569.82M | -590.48M | -488.13M | -744.16M | -697.38M | -690.98M | -585.94M | -410.65M | -645.18M | -531.72M | -449.82M | -429.08M | -421.97M | -337.56M | -243.91M | -189.94M | -158.59M | -185.34M |
Book Value Per Share | -1 | -0.85 | -0.50 | -0.55 | -0.64 | -0.69 | -0.66 | -1.07 | -1.02 | -1.03 | -0.99 | -0.82 | -1.47 | -1.24 | -1.11 | -1.07 | -1.06 | -0.85 | -0.61 | -0.48 | -0.41 | -0.48 |
Common Stock | n/a | 104K | 101K | 98K | 91K | 85K | 85K | 70K | 69K | 68K | 67K | 67K | 44K | 43K | 42K | 40K | 40K | 40K | 40K | 39K | 39K | 38K |
Retained Earnings | n/a | -4.36B | -3.73B | -3.66B | -3.6B | -3.5B | -3.38B | -3.32B | -3.23B | -3.1B | -2.96B | -2.73B | -2.63B | -2.49B | -2.38B | -2.27B | -2.16B | -2.06B | -1.96B | -1.87B | -1.78B | -1.69B |
Comprehensive Income | n/a | 27.45M | 28.96M | 5M | 12.57M | 19.96M | 1.2M | 103K | -8K | -7K | 10K | 792K | -40K | -33K | 183K | -190K | -110K | -367K | 4K | 53K | 37K | -38K |
Shareholders Equity | -1.05B | -870.01M | -499.57M | -524.32M | -570.75M | -591.43M | -489.1M | -745.15M | -698.39M | -692.01M | -586.99M | -411.72M | -642.12M | -528.98M | -447.33M | -426.7M | -419.82M | -335.64M | -242.17M | -188.5M | -157.94M | -185.79M |
Total Investments | 281.7M | 185.69M | 164.96M | 205.59M | 23.95M | 8.12M | 7.08M | 18.4M | 87.88M | 37.46M | 1.9M | 12.65M | 3.29M | 3.61M | 3.38M | 7.71M | 21.95M | 156.81M | 142.79M | 24.11M | 20.79M | 46.77M |
Add to Watchlist
Select watchlists to add or remove IBRX